Harmony Biosciences Holdings (HRMY) Asset Utilization Ratio (2020 - 2026)

Harmony Biosciences Holdings (HRMY) has 7 years of Asset Utilization Ratio data on file, last reported at 0.71 in Q1 2026.

• For the quarter ending Q1 2026, Asset Utilization Ratio fell 2.48% year-over-year to 0.71; the trailing twelve-month figure through Mar 2026 stood at 0.71 (down 2.48% YoY), and the FY2025 full-year result was 0.76, down 3.12% from the prior year.
• Asset Utilization Ratio advanced to 0.71 in Q1 2026, from 0.7 in the prior quarter.
• In the past five years, Asset Utilization Ratio ranged from a high of 0.77 in Q2 2024 to a low of 0.66 in Q4 2022.
• A 5-year average of 0.72 and a median of 0.71 in 2025 frame the typical range for Asset Utilization Ratio.
• Peak annual rise in Asset Utilization Ratio reached 41.28% in 2022, while the deepest fall reached 10.27% in 2022.
• Tracing HRMY's Asset Utilization Ratio over 5 years: stood at 0.66 in 2022, then climbed by 10.19% to 0.73 in 2023, then climbed by 1.26% to 0.74 in 2024, then slipped by 5.56% to 0.7 in 2025, then grew by 0.94% to 0.71 in 2026.
• Business Quant data shows HRMY's Asset Utilization Ratio at 0.71 in Q1 2026, 0.7 in Q4 2025, and 0.71 in Q3 2025.